Odyssey Therapeutics, Inc.
corporate_fare Company Profile
Odyssey Therapeutics, Inc. (NASDAQ:ODTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for ODTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-08, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for ODTX spans 8-K, 10-Q, SCHEDULE 13D, 424B4.
Recent high-impact activity:
- Pipeline Update: OD-002 CTA Filing on Track for H2 2026, Detailed OD-001 Phase 2a Results
- Odyssey Therapeutics Partners with Evotec on AI-Driven Autoimmune Drug Discovery
- Odyssey Therapeutics Q2 2026: Cash Runway Extended to H2 2028, OD-001 Phase 2a Costs Drive R&D Increase
- Odyssey Q2 2026: $433M Cash and Pipeline Progress, with OD-001 Data Headed to UEG Week
- Odyssey Therapeutics Posts Q2 Loss, Cash Runway Into 2028; Key Trials on Track
Short Interest & Short Volume
10.78 days to coverFINRA reported short interest of 2,208,686 shares in ODTX as of the September 15, 2026 settlement, unchanged from the prior period — about 10.8 days to cover at its recent average daily volume. On October 2, 2026, 60.0% of ODTX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for ODTX, detected from its recent SEC filings · based on capital-structure filings through 2026-05-08.
Initial Public Offering (IPO) Priced · Concurrent Private Placement
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →